摘要 目的：研究荷芪散聯合二甲双胍对多囊卵巢综合征(Polycystic Ovary Syndrome，PCOS)伴胰岛素抵抗(Insulin Resistance，IR)的临床疗效。方法：选取2015年1月至2016年1月深圳市中医院住院及门诊治疗的多囊卵巢综合征患者共90例，随机分为A组(中药组)、B组(西药组)、C组(中西药组)，每组30例。中药组予荷芪散，西药组予二甲双胍，中西药组予荷芪散加二甲双胍。观察治疗前后临床症状、糖代谢及胰岛素抵抗指标、性激素水平的变化。结果：治疗3个月后，中西药组临床症状改善优于中药组及西药组(P, http://www.100md.com
 关键词 多囊卵巢综合征；荷芪散；二甲双胍；胰岛素抵抗；性激素

 Clinical Study on Heqi Powder Combined with Metformin in Treating Polycystic Ovary Syndrome with Insulin Resisitance

 Liu Ling1， Zhao Hengxia1， Li Huilin1， Chu Shufang1， Liu Xuemei1， Liu Deliang1，Zhang Xuewen2

 (1 Endocrine Department， Shenzhen Hospital of Traditional Medicine， Shenzhen 518033， China； 2 Shaanxi University of traditional Chinese medicine， Xianyang 712046， China)
, 百拇医药
 Abstract Objective：To observe the clinical curative effect of Heqi Powder combined with Metformin in treating PCOS with insulin resistance.Methods：Ninety patients who met the criteria were included and randomly divided into group A (Chinese medicine group)， group B (western medicine group) and group C (Chinese-western medicine group)， with 30 cases in each group. Chinese medicine group took Heqi Powder， western medicine group took metformin， while the Chinese-western medicine group took Heqi Powder plus metformin. Clinical syndromes， glucose metabolic and insulin resistant parameters and sex hormone levels of the two groups before and after the treatment were compared.Results：After 3-month treatment， improvement in clinical syndromes of the Chinese-western medicine group was better than Chinese group and western medicine group (P, 百拇医药(刘玲 赵恒侠 李惠林 楚淑芳 刘雪梅 刘德亮 张学文) 第 1 2 3 4 页 下一页

 参见：首页 > 医疗版 > 疾病专题 > 妇产科 > 妇科综合征及其它 > 多囊卵巢综合征
 百拇医药网 http://www.100md.com/html/paper/1673-7202/2017/08/27.htm